Deal Watch: Mylan Proposes $30 Billion Purchase Of Perrigo
Executive Summary
Bristol increases R&D emphasis on gene therapy through a collaboration with Dutch biotech uniQure, paying $50 million up front with numerous potential earn-outs. Astellas becomes the third pharma to sign a “Moon Shots” partnership with MD Anderson Cancer Center.